{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:39:17Z","timestamp":1793255957989,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejps.2023.106375","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T02:07:25Z","timestamp":1673057245000},"page":"106375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc Receptor (FcRn) in human tissues and implications for pharmacokinetic modelling"],"prefix":"10.1016","volume":"182","author":[{"given":"Jill","family":"Barber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubida M.","family":"Al-Majdoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narciso","family":"Couto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyn","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Elmorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Scotcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naved","family":"Alizai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"de Wildt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Stader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Sepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Rostami-Hodjegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2595-5626","authenticated-orcid":false,"given":"Brahim","family":"Achour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2023.106375_bib0001","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/cpt.2102","article-title":"Liquid biopsy enables quantification of the abundance and interindividual variability of hepatic enzymes and transporters","volume":"109","author":"Achour","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2023.106375_bib0002","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/cpt.2576","article-title":"Liquid biopsy for patient characterization in cardiovascular disease: verification against markers of cytochrome P450 and P-glycoprotein activities","volume":"111","author":"Achour","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2023.106375_bib0003","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/jnc.14446","article-title":"Identification and quantification of blood-brain barrier transporters in isolated rat brain microvessels","volume":"146","author":"Al Feteisi","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejps.2023.106375_bib0004","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1021\/pr400667h","article-title":"Quantification of the proteins of the bacterial ribosome using QconCAT technology","volume":"13","author":"Al-Majdoub","year":"2014","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejps.2023.106375_bib0005","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1002\/1873-3468.13982","article-title":"Mass spectrometry-based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin","volume":"594","author":"Al-Majdoub","year":"2020","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejps.2023.106375_bib0006","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1021\/acs.molpharmaceut.8b01189","article-title":"Proteomic quantification of human blood\u2013brain barrier SLC and ABC transporters in healthy individuals and dementia patients","volume":"16","author":"Al-Majdoub","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2023.106375_bib0007","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/cpt.2097","article-title":"Quantification of proteins involved in intestinal epithelial handling of xenobiotics","volume":"109","author":"Al-Majdoub","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2023.106375_bib0008","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/cpt.2396","article-title":"Quantitative proteomic map of enzymes and transporters in the human kidney: stepping closer to mechanistic kidney models to define local kinetics","volume":"110","author":"Al-Majdoub","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2023.106375_bib0009","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1023\/A:1020917122093","article-title":"Population pharmacokinetics and pharmacodynamics of the anti-CD11a antibody hu1124 in human subjects with psoriasis","volume":"27","author":"Bauer","year":"1999","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejps.2023.106375_bib0010","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/19420862.2018.1462429","article-title":"Linear pharmacokinetic parameters for monoclonal antibodies are similar within a species and across different pharmacological targets: a comparison between human, cynomolgus monkey and hFcRn Tg32 transgenic mouse using a population-modeling approach","volume":"10","author":"Betts","year":"2018","journal-title":"MAbs"},{"key":"10.1016\/j.ejps.2023.106375_bib0011","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/372336a0","article-title":"Crystal structure at 2.2\u00c5 resolution of the MHC-related neonatal Fc receptor","volume":"372","author":"Burmeister","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2023.106375_bib0012","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1002\/cam4.3067","article-title":"The neonatal Fc receptor in cancer FcRn in cancer","volume":"9","author":"Cadena Castaneda","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.ejps.2023.106375_bib0013","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/19420862.2019.1602459","article-title":"Neonatal Fc receptor expression in macrophages is indispensable for IgG homeostasis","volume":"11","author":"Challa","year":"2019","journal-title":"MAbs"},{"key":"10.1016\/j.ejps.2023.106375_bib0014","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.xphs.2020.05.025","article-title":"Whole-body pharmacokinetics of antibody in mice determined using enzyme-linked immunosorbent assay and derivation of tissue interstitial concentrations","volume":"110","author":"Chang","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106375_bib0015","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2014.00670","article-title":"Prediction of the pharmacokinetics, pharmacodynamics, and efficacy of a monoclonal antibody, using a physiologically based pharmacokinetic FcRn model","volume":"5","author":"Chetty","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2023.106375_bib0016","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1021\/acs.molpharmaceut.8b00941","article-title":"Quantification of proteins involved in drug metabolism and disposition in the human liver using label-free global proteomics","volume":"16","author":"Couto","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2023.106375_bib0017","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1124\/dmd.119.089656","article-title":"Quantitative proteomics of clinically relevant drug-metabolizing enzymes and drug transporters and their intercorrelations in the human small intestine","volume":"48","author":"Couto","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2023.106375_bib0018","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1124\/dmd.120.000168","article-title":"Label-free quantitative proteomics and substrate-based mass spectrometry imaging of xenobiotic metabolizing enzymes in ex vivo human skin and a human living skin equivalent model","volume":"49","author":"Couto","year":"2021","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2023.106375_bib0019","doi-asserted-by":"crossref","first-page":"54415","DOI":"10.18632\/oncotarget.10074","article-title":"Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis","volume":"7","author":"Dalloneau","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejps.2023.106375_bib0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev-pharmtox-033020-113257","article-title":"Model-informed precision dosing: background, requirements, validation, implementation, and forward trajectory of individualizing drug therapy","volume":"61","author":"Darwich","year":"2021","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejps.2023.106375_bib0021","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40262-012-0027-4","article-title":"Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies","volume":"52","author":"Dostalek","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2023.106375_bib0022","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/19420862.2017.1337619","article-title":"Quantification of IgG monoclonal antibody clearance in tissues","volume":"9","author":"Eigenmann","year":"2017","journal-title":"MAbs"},{"key":"10.1016\/j.ejps.2023.106375_bib0023","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1124\/dmd.120.000152","article-title":"Scaling factors for clearance in adult liver cirrhosis","volume":"48","author":"El-Khateeb","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2023.106375_bib0024","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ejps.2023.106375_bib0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/biom9080373","article-title":"Human FcRn tissue expression profile and half-life in PBMCs","volume":"9","author":"Fan","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejps.2023.106375_bib0026","unstructured":"Food and Drug Administration (2020) Enhancing the diversity of clinical trial populations \u2013 eligibility criteria, enrollment practices, and trial designs, Guidance for Industry. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/enhancing-diversity-clinical-trial-populations-eligibility-criteria-enrollment-practices-and-trial."},{"key":"10.1016\/j.ejps.2023.106375_bib0027","unstructured":"Food and Drug Administration (2022), Diversity plans to improve enrollment of participants from underrepresented racial and ethnic populations in clinical trials, Draft Guidance for Industry, (2022). Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/diversity-plans-improve-enrollment-participants-underrepresented-racial-and-ethnic-populations."},{"key":"10.1016\/j.ejps.2023.106375_bib0028","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1208\/s12248-015-9819-4","article-title":"A bottom-up whole-body physiologically based pharmacokinetic model to mechanistically predict tissue distribution and the rate of subcutaneous absorption of therapeutic proteins","volume":"18","author":"Gill","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2023.106375_bib0029","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2249.2007.03545.x","article-title":"Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities","volume":"151","author":"Gonzalez-Quintela","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejps.2023.106375_bib0030","first-page":"1144","article-title":"Effects of the FcRn developmental pharmacology on the pharmacokinetics of therapeutic monoclonal IgG antibody in pediatric subjects using minimal physiologically-based pharmacokinetic modelling","volume":"10","author":"Hardiansyah","year":"2018","journal-title":"MAbs"},{"key":"10.1016\/j.ejps.2023.106375_bib0031","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/bdd.1810","article-title":"Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption","volume":"34","author":"Harwood","year":"2013","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2023.106375_bib0032","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1200\/JCO.2005.05.145","article-title":"Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling","volume":"23","author":"Jansen","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejps.2023.106375_bib0033","doi-asserted-by":"crossref","first-page":"11577","DOI":"10.1096\/fj.201902515RR","article-title":"Bivalent engagement of endothelial surface antigens is critical to prolonged surface targeting and protein delivery in vivo","volume":"34","author":"Kiseleva","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.ejps.2023.106375_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115942","article-title":"Influence of FcRn binding properties on the gastrointestinal absorption and exposure profile of Fc molecules","volume":"32","author":"Lawrence","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106375_bib0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1124\/dmd.121.000623","article-title":"Ontogeny of scaling factors for pediatric physiology-based pharmacokinetic modeling and simulation: microsomal protein per gram of liver","volume":"50","author":"Leeder","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2023.106375_bib0036","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1208\/s12248-014-9640-5","article-title":"Simulation of monoclonal antibody pharmacokinetics in humans using a minimal physiologically based model","volume":"16","author":"Li","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2023.106375_bib0037","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1023\/A:1018853506830","article-title":"Ontogenetic development and distribution of antibody transport and Fc receptor mRNA expression in rat intestine","volume":"42","author":"Mart\u00edn","year":"1997","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ejps.2023.106375_bib0038","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/cpt.1778","article-title":"Virtual twins: understanding the data required for model-informed precision dosing","volume":"107","author":"Polasek","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2023.106375_bib0039","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1242\/jcs.115.11.2389","article-title":"\u03b22-microglobulin is important for cell surface expression and pH-dependent IgG binding of human FcRn","volume":"115","author":"Praetor","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejps.2023.106375_bib0040","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.3389\/fimmu.2019.01540","article-title":"The neonatal Fc receptor (FcRn): a misnomer?","volume":"10","author":"Pyzik","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2023.106375_bib0041","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1124\/dmd.120.000075","volume":"48","author":"Qiu","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2023.106375_bib0042","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejps.2023.106375_bib0043","series-title":"Advances in Pharmacokinetics and Pharmacodynamics","article-title":"On the verge of impossibility: accounting for variability arising from permutations of comorbidities that affect the fate of drugs in the human body","author":"Rostami-Hodjegan","year":"2022"},{"key":"10.1016\/j.ejps.2023.106375_bib0044","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.1021\/pr400279u","article-title":"Alternative fusion protein strategies to express recalcitrant QconCAT proteins for quantitative proteomics of human drug metabolizing enzymes and transporters","volume":"12","author":"Russell","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejps.2023.106375_bib0045","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1124\/dmd.117.075242","article-title":"Microsomal and cytosolic scaling factors in dog and human kidney cortex and application for in vitro-in vivo extrapolation of renal metabolic clearance","volume":"45","author":"Scotcher","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2023.106375_bib0046","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1186\/s12885-016-2851-7","article-title":"KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma","volume":"16","author":"Shi","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejps.2023.106375_bib0047","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/138920021503140412212905","article-title":"Biologics: an update and challenge of their pharmacokinetics","volume":"15","author":"Shi","year":"2014","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejps.2023.106375_bib0048","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/eji.1830150718","article-title":"Isolation and characterization of an Fc receptor from neonatal rat small intestine","volume":"15","author":"Simister","year":"1985","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejps.2023.106375_bib0049","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1084\/jem.20020400","article-title":"Receptor-mediated Immunoglobulin G Transport Across Mucosal Barriers in Adult Life","volume":"196","author":"Spiekermann","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejps.2023.106375_bib0050","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1084\/jem.180.6.2377","article-title":"A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus","volume":"180","author":"Story","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejps.2023.106375_bib0051","series-title":"Pharmacokinetics and Pharmacodynamics of Biotech Drugs","first-page":"15","article-title":"Pharmacokinetics of Peptides and Proteins","author":"Tang","year":"2006"},{"key":"10.1016\/j.ejps.2023.106375_bib0052","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/jps.21918","article-title":"Physiologically based pharmacokinetic model for T84.66: a monoclonal anti-CEA antibody","volume":"99","author":"Urva","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106375_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2022.104601","article-title":"Proteomic quantification of perturbation to pharmacokinetic target proteins in liver disease","volume":"263","author":"Vasilogianni","year":"2022","journal-title":"J. Proteom."},{"key":"10.1016\/j.ejps.2023.106375_bib0054","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1074\/mcp.M113.037309","article-title":"A \u201cproteomic ruler\u201d for protein copy number and concentration estimation without spike-in standards","volume":"13","author":"Wi\u015bniewski","year":"2014","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.ejps.2023.106375_bib0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wi\u015bniewski","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejps.2023.106375_bib0056","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/0091270012436560","article-title":"Comparison of subcutaneous and intravenous administration of trastuzumab: a Phase I\/Ib trial in healthy male volunteers and patients with HER2-positive breast cancer","volume":"53","author":"Wynne","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2023.106375_bib0057","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/282989","article-title":"Pharmacokinetic models for FcRn-mediated IgG disposition","volume":"2012","author":"Xiao","year":"2012","journal-title":"J. Biomed. Biotechnol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723000064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723000064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:05:54Z","timestamp":1760529954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098723000064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":57,"alternative-id":["S0928098723000064"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106375","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc Receptor (FcRn) in human tissues and implications for pharmacokinetic modelling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106375"}}